// App-Quantinova.ai

181 : Safety Update on Certolizumab Pegol in Patients with Active Rheumatoid Arthritis with Long Term Exposure

Researchers

Presenter

  • Ronald Van Vollenhoven

Principal Investigators

  • Vivian Bykerk

  • Marc de Longueville

  • Catherine Arendt

  • Kristel Luijtens

  • Jack Cush

Medical Centers

  • Mount Sinai Hospital, Toronto, ON, Canada

  • Paris, France

Locations

  • France

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Rheumatoid arthritis

  • Solid malignancies

  • Skin carcinoma

  • Inflammatory Arthritis

  • Lymphomas

  • Melanoma

Biomarkers

  • N/A

Drug/Treatment

  • Certolizumab pegol

Outcome

  • Unknown

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved